Suppr超能文献

儿童未确诊哮喘却开具呼吸类药物处方:一项基于人群的研究。

Prescription of respiratory medication without an asthma diagnosis in children: a population based study.

作者信息

Zuidgeest Mira G P, van Dijk Liset, Smit Henriette A, van der Wouden Johannes C, Brunekreef Bert, Leufkens Hubert G M, Bracke Madelon

机构信息

Department of Pharmacoepidemiology & Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, The Netherlands.

出版信息

BMC Health Serv Res. 2008 Jan 22;8:16. doi: 10.1186/1472-6963-8-16.

Abstract

BACKGROUND

In pre-school children a diagnosis of asthma is not easily made and only a minority of wheezing children will develop persistent atopic asthma. According to the general consensus a diagnosis of asthma becomes more certain with increasing age. Therefore the congruence between asthma medication use and doctor-diagnosed asthma is expected to increase with age. The aim of this study is to evaluate the relationship between prescribing of asthma medication and doctor-diagnosed asthma in children age 0-17.

METHODS

We studied all 74,580 children below 18 years of age, belonging to 95 GP practices within the second Dutch national survey of general practice (DNSGP-2), in which GPs registered all physician-patient contacts during the year 2001. Status on prescribing of asthma medication (at least one prescription for beta2-agonists, inhaled corticosteroids, cromones or montelukast) and doctor-diagnosed asthma (coded according to the International Classification of Primary Care) was determined.

RESULTS

In total 7.5% of children received asthma medication and 4.1% had a diagnosis of asthma. Only 49% of all children receiving asthma medication was diagnosed as an asthmatic. Subgroup analyses on age, gender and therapy groups showed that the Positive Predictive Value (PPV) differs significantly between therapy groups only. The likelihood of having doctor-diagnosed asthma increased when a child received combination therapy of short acting beta2-agonists and inhaled corticosteroids (PPV = 0.64) and with the number of prescriptions (3 prescriptions or more, PPV = 0.66). Both prescribing of asthma medication and doctor-diagnosed asthma declined with age but the congruence between the two measures did not increase with age.

CONCLUSION

In this study, less than half of all children receiving asthma medication had a registered diagnosis of asthma. Detailed subgroup analyses show that a diagnosis of asthma was present in at most 66%, even in groups of children treated intensively with asthma medication. Although age strongly influences the chance of being treated, remarkably, the congruence between prescribing of asthma medication and doctor-diagnosed asthma does not increase with age.

摘要

背景

在学龄前儿童中,哮喘的诊断并不容易,只有少数喘息儿童会发展为持续性特应性哮喘。根据普遍共识,随着年龄增长,哮喘诊断的确定性会增加。因此,哮喘药物使用与医生诊断的哮喘之间的一致性预计会随着年龄增长而增加。本研究的目的是评估0至17岁儿童哮喘药物处方与医生诊断的哮喘之间的关系。

方法

我们研究了参与荷兰第二次全科医疗全国调查(DNSGP - 2)的95家全科医疗诊所中所有74580名18岁以下儿童,全科医生在该调查中记录了2001年期间所有医患接触情况。确定了哮喘药物处方状态(至少一张β2激动剂、吸入性糖皮质激素、色酮类药物或孟鲁司特的处方)以及医生诊断的哮喘(根据国际初级保健分类编码)。

结果

总共有7.5%的儿童接受了哮喘药物治疗,4.1%被诊断为哮喘。在所有接受哮喘药物治疗的儿童中,只有49%被诊断为哮喘患者。按年龄、性别和治疗组进行的亚组分析表明,仅治疗组之间的阳性预测值(PPV)存在显著差异。当儿童接受短效β2激动剂和吸入性糖皮质激素联合治疗时(PPV = 0.64)以及随着处方数量增加(3张或更多处方,PPV = 0.66),被医生诊断为哮喘的可能性增加。哮喘药物处方和医生诊断的哮喘均随年龄下降,但这两项指标之间的一致性并未随年龄增加。

结论

在本研究中,所有接受哮喘药物治疗的儿童中,不到一半有哮喘的登记诊断。详细的亚组分析表明,即使在接受强化哮喘药物治疗的儿童组中,哮喘诊断最多也只有66%。虽然年龄对接受治疗的机会有很大影响,但值得注意的是,哮喘药物处方与医生诊断的哮喘之间的一致性并未随年龄增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e85d/2245932/c84ea7f91e9d/1472-6963-8-16-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验